GlassScriptPhysician profile
Shelley D Padgett
NPI 1588146039
$2,396.01
in general payments reported to CMS, 2019-2025
20 companies · $49.59 in 2025
The $49.59 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,880 · 2022: $414 · 2023: $52.64 · 2025: $49.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $102.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $102.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $462.71 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $285.06 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $265.04 | 2021-2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $224.50 | 2021-2022 | |
| Bausch Health US, LLC | $204.74 | 2021-2022 | |
| Alkermes, INC. | $174.76 | 2021-2022 | |
| Lundbeck LLC | $161.46 | 2021 | |
| Vanda Pharmaceuticals INC. | $159.14 | 2021 | |
| Sunovion Pharmaceuticals INC. | $143.15 | 2021-2022 | |
| Axsome Therapeutics, INC. | $49.59 | 2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $43.49 | 2022 | |
| Acadia Pharmaceuticals INC | $37.34 | 2021 | |
| Merck Sharp & Dohme LLC | $34.72 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $29.67 | 2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $24.43 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $23.79 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.29 | 2021 | |
| Avanir Pharmaceuticals, INC. | $18.60 | 2021 | |
| Eisai INC. | $18.19 | 2021 | |
| Ironshore Pharmaceuticals INC. | $15.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shelley Padgett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.